ASML vs CORT · P/E 57, $665.37B cap vs P/E 199, rev $675.0M
ASML Holding NV ADR (ASML) versus Corcept Therapeutics Incorporated (CORT) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
ASML does not have a complete income-statement cache yet.
Latest reported CORT revenue for 2024-12-31 was $675.0M. Net income was $141.2M. Revenue was up 39.9% from 2023-12-31 to 2024-12-31. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Not investment advice. Open the ASML and CORT stock pages for the full models.
Not investment advice.